Same here - 2019 gleason 6 in only 2 cores of 12, genetic test (one of the first available at that time ) showed "low " risk , like in 30 years low "prediction". Six years later - IDC-P with cribriform : (. That is why biopsy should be done every 2-3 years once gleason of any kind is discovered.

I think that it is unconscionable to tell patients that 3+3 means "nothing" and that it is not even cancer ! IT IS CANCER and should be alarming in a sense that "ultra active surveillance" should be initiated at that point no matter what MRI shows or what PSA level is .

What is the point of "active surveillance" if it does not find out cancer in 3+4 stage and localized ???? Now that PSMA /CT is available it should be part of active surveillance every 2 years .